Latest News
GSK plc
- GSK brings promise of 'functional cure' to hepatitis B finish line with FDA nod for Hibsago
- GSK’s Jemperli scores FDA approval in rectal cancer, backed by high complete response rate
- GSK showcases pipeline momentum across lung, gynaecological and gastrointestinal cancers at ESMO 2026
- Strikes at GSK’s Belgian sites over plans to cut 1200 jobs
- GSK shares gain almost 2% after CEO and CFO increase holdings and technical momentum builds
- GSK plans to cut up to 1,217 jobs in Belgium as it begins three-year restructuring plan
- GSK to lay off over 1,200 roles in Belgium as cost-saving program picks up steam
- GSK could cut more than 1,200 jobs in Belgium
- GSK to invest $800M in Pennsylvania expansion
- Exclusive: AI startup Chai lands GSK deal, its sixth pharma partner in nine months
- Pennsylvania says GSK to invest more than $800 million in biopharma hub, create 300 jobs
- GSK drinks in Chai Discovery’s AI models after wet-lab validation
Headlines from the last 30 days, linking to the original publishers. See all market news →